Page 337 - Vitamin D and Cancer

324 R. Vieth

8. Stolzenberg-Solomon RZ, Vieth R, Azad A, Pietinen P, Taylor PR, Virtamo J et al (2006)
A prospective nested case-control study of vitamin D status and pancreatic cancer risk in male
smokers. Cancer Res 66(20):10213–10219
9. Oh EY, Ansell C, Nawaz H, Yang CH, Wood PA, Hrushesky WJ (2010) Global breast cancer
seasonality. Breast Cancer Res Treat (Pub Online First) Feb 4
10. Holdaway IM, Mason BH, Gibbs EE, Rajasoorya C, Lethaby A, Hopkins KD et al (1997)
Seasonal variation in the secretion of mammotrophic hormones in normal women and women
with previous breast cancer. Breast Cancer Res Treat 42(1):15–22
11. Tokar EJ, Webber MM (2005) Chemoprevention of prostate cancer by cholecalciferol
(vitamin D3): 25-hydroxylase (CYP27A1) in human prostate epithelial cells. Clin Exp
Metastasis 22(3):265–273
12. Krishnan AV, Peehl DM, Feldman D (2003) Inhibition of prostate cancer growth by vitamin
D: Regulation of target gene expression. J Cell Biochem 88(2):363–371
13. Chen TC, Holick MF (2003) Vitamin D and prostate cancer prevention and treatment. Trends
Endocrinol Metab 14(9):423–430
14. Krishnan AV, Feldman D (2010) Molecular pathways mediating the anti-inflammatory effects
of calcitriol: implications for prostate cancer chemoprevention and treatment. Endocr Relat
Cancer 17(1):R19–R38
15. Bao BY, Yeh SD, Lee YF (2006) 1{alpha}, 25-dihydroxyvitamin D3 inhibits prostate cancer
cell invasion via modulation of selective proteases. Carcinogenesis 27(1):32–42
16. Zhang X, Jiang F, Li P, Li C, Ma Q, Nicosia SV et al (2005) Growth suppression of ovarian cancer
xenografts in nude mice by vitamin D analogue EB1089. Clin Cancer Res 11(1):323–328
17. Sundaram S, Sea A, Feldman S, Strawbridge R, Hoopes PJ, Demidenko E et al (2003) The
combination of a potent vitamin D3 analog, EB 1089, with ionizing radiation reduces tumor
growth and induces apoptosis of MCF-7 breast tumor xenografts in nude mice. Clin Cancer
Res 9(6):2350–2356
18. Elstner E, Campbell MJ, Munker R, Shintaku P, Binderup L, Heber D et al (1999) Novel
20-epi-vitamin D3 analog combined with 9-cis-retinoic acid markedly inhibits colony growth
of prostate cancer cells. Prostate 40(3):141–149
19. Polek TC, Stewart LV, Ryu EJ, Cohen MB, Allegretto EA, Weigel NL (2003) p53 Is required
for 1, 25-dihydroxyvitamin D3-induced G0 arrest but is not required for G1 accumulation or
apoptosis of LNCaP prostate cancer cells. Endocrinology 144(1):50–60
20. Vegesna V, O’Kelly J, Said J, Uskokovic M, Binderup L, Koeffle HP (2003) Ability of potent
vitamin D3 analogs to inhibit growth of prostate cancer cells in vivo. Anticancer Res
23(1A):283–289
21. Peleg S, Khan F, Navone NM, Cody DD, Johnson EM, Pelt CS et al (2005) Inhibition of
prostate cancer-meditated osteoblastic bone lesions by the low-calcemic analog 1alpha-
hydroxymethyl-16-ene-26, 27-bishomo-25-hydroxy vitamin D(3). J Steroid Biochem Mol
Biol 97(1–2):203–211
22. Huang DC, Papavasiliou V, Rhim JS, Horst RL, Kremer R (2002) Targeted disruption of the
25-hydroxyvitamin D3 1alpha-hydroxylase gene in ras-transformed keratinocytes demon-
strates that locally produced 1alpha, 25-dihydroxyvitamin D3 suppresses growth and induces
differentiation in an autocrine fashion. Mol Cancer Res 1(1):56–67
23. Bouillon R, Moody T, Sporn M, Barrett JC, Norman AW (2005) NIH deltanoids meeting on
Vitamin D and cancer. Conclusion and strategic options. J Steroid Biochem Mol Biol
97(1–2):3–5
24. Travis RC, Crowe FL, Allen NE, Appleby PN, Roddam AW, Tjonneland A et al (2009) Serum
Vitamin D and risk of prostate cancer in a case-control analysis nested within the European
Prospective Investigation into Cancer and Nutrition (EPIC). Am J Epidemiol
169(10):1223–1232
25. Luscombe CJ, French ME, Liu S, Saxby MF, Jones PW, Fryer AA et al (2001) Prostate cancer
risk: associations with ultraviolet radiation, tyrosinase and melanocortin-1 receptor geno-
types. Br J Cancer 85(10):1504–1509
26. Schwartz GG, Hanchette CL (2006) UV, latitude, and spatial trends in prostate cancer mortal-
ity: all sunlight is not the same (United States). Cancer Causes Control 17(8):1091–1101